We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ULTOMIRIS ravulizumab rch 300 mg in 3 mL (100 mg/mL) concentrated solution for injection by intravenous infusion vial (330566)
ARTG ID 330566
ARTG Name
ULTOMIRIS ravulizumab rch 300 mg in 3 mL (100 mg/mL) concentrated solution for injection by intravenous infusion vial
Product name
ULTOMIRIS ravulizumab rch 300 mg in 3 mL (100 mg/mL) concentrated solution for injection by intravenous infusion vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicines
Ingredients
ravulizumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information